Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: Cancer Res. 2017 Jul 7;77(18):5011–5025. doi: 10.1158/0008-5472.CAN-16-2704

Table 1. Models to evaluate the role of HuR in PARPi response.

Table indicates the IC50 values of 1) (CRISPR)-generated PDA cell lines DDR- P MIA PaCa-2 and DDR- D Hs 766T with HuR genetically knocked out [HuR (+/+), HuR (−/−)]; 2) siRNA oligos against the HuR coding region as previously described (17, 20); 3) a small molecule inhibitor, MS-444 (40).

DDR
status
Cell lines Olaparib Veliparib Rucaparib
IC50
μM
Fold-
change
P-value
(two-
tailed)
IC50
μM
Fold-
change
P-value
(two-
tailed)
IC50
μM
Fold-
change
P-value
(two-
tailed)
CRIPSR knockout Deficient HST.HuR(+/+) 8.30 21.8 >0.0001 2.20 2.6 0.0009 4.56 12.6 >0.0001
HST.HuR(−/−) 0.38 0.85 0.36
Proficient MIA.HuR(+/+) 12.52 21.9 >0.0001 12.04 15.5 >0.0001 10.22 20.8 >0.0001
MIA.HuR(−/−) 0.57 0.76 0.49
siRNA silencing Deficient Capan-1
siCon
1.28 3.5 >0.0001 4.25 10.1 >0.0001 10.40 5.3 >0.0001
Capan-1
siHuR
0.36 0.42 1.95
Deficient Hs 766T
siCon
8.40 3.8 >0.0001 6.25 2.0 >0.0001 9.25 2.76 >0.0001
Hs 766T
siHuR
2.24 3.12 3.35
Proficient MIA PaCa-2
siCon
13.21 6.20 >0.0001 13.32 5.3 >0.0001 15.60 6.24 >0.0001
MIA PaCa-2
siHuR
2.13 2.50 2.50
Deficient Capan-1 (Vehicle) 1.87 3.0 0.0009 1.20 2.1 0.0009 1.65 3.8 >0.0001
Capan-1 (MS-444) 0.62 0.56 0.43
Small Molecule inhibition (MS-444) Deficient Hs 766T (Vehicle) 4.32 2.3 >0.001 3.0 4.1 >0.0001 4.18 3.2 >0.001
Hs 766T (MS-444) 1.87 0.73 1.31
Proficient MIA PaCa-2 (Vehicle) 11.67 4.4 >0.0001 12.56 4.0 >0.0001 11.88 3.2 0.0009
MIA PaCa-2 (MS-444) 2.68 3.20 3.68